Design, synthesis, and biological evaluation of novel 4,4′-bipyridine derivatives acting as CDK9-Cyclin T1 protein-protein interaction inhibitors against triple-negative breast cancer
Gui‐Ping Gao, Jiayi Li, Yin Cao, Xudan Li, Yuqing Qian, Xiumei Wang, Mengyu Li, Ying‐Kun Qiu, Tong Wu, Liqiang Wang, Meijuan Fang, Meijuan Fang
Topics & Concepts
OlaparibPARP inhibitorTriple-negative breast cancerChemistryCancer researchCyclin-dependent kinaseKinasePharmacologyCancerBreast cancerBiochemistryPoly ADP ribose polymeraseCell cycleCellMedicinePolymeraseInternal medicineEnzymePARP inhibition in cancer therapyCancer-related Molecular PathwaysProtein Degradation and Inhibitors